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Kidney Res Clin Pract 31 (2012) A16–A96A36charts. Results: Patients were classiﬁed into one of three categories, based on
their SGA score (A) Well-nourished; (B) Mild- Moderate Malnutrition,
(C) Severe malnutrition. Malnutrition (B or C) was detected in 10% of PD
patients, compared to the 2008/09 audit where 76% of MPD patients had some
degree of malnutrition. Summary: These results were much lower than
malnutrition rates (76%) in the MPD patients audited in 2008/09. A number of
factors affecting the PD service after the 2008/09 audit could explain the
decrease in malnutrition rates including the implementation of free oral
nutrition supplements to MPD patients, development of service wide culturally
appropriate education resources used in the pre-dialysis and dialysis stage.
Future research into the correlation between improved peritonitis rates and
decreased malnutrition rates in the population are warranted.
http://dx.doi.org/10.1016/j.krcp.2012.04.40178
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Protein-energy wasting (PEW) is crucial complication in prevalent
hemodialysis (HD) patients. Abnormality of biomarkers such as IL-6, NT-pro-
BNP, and adiponectin (ADPN) contribute to PEW. However, associations of the
biomarkers with PEW according to BMI levels have not been fully evaluated.
Thus those associations were assessed by a cross-sectional cohort study of
prevalent HD patients (n¼386). PEW was deﬁned by subjective global
assessment (n¼108). IL-6 levels were inversely, and NT-pro-BNP and ADPN
levels were positively correlated with BMI levels. Odds ratio (OR) of log IL-6 (OR
1.5, CI 1.0, 2.2), log NT-pro-BNP (OR 1.7, CI 1.3, 2.2), and log ADPN (OR 1.9, CI
1.1, 3.2) to PEW were signiﬁcantly increased in logistic multivariate regression
model. ORs of log NT-pro-BNP and log ADPN for PEW were progressively
increased in patients with threshold 21 kg/m2oBMI, but progressively
decreased in those below this threshold. On the other hand, OR of log IL-6 for
PEW was progressively decreased in patients with threshold 21 kg/m2oBMI,
but similar in those below this threshold. These associations were conﬁrmed by
the models adjusted with confounder. In conclusions, predictive values of IL-6,
NT-pro-BNP and ADPN for PEW state may be dependent on BMI levels in
prevalent HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.40279
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The aim of this study was to investigate the incidence and clinical
features of EPS in PD patients from a single university center in Korea. The
data were retrospectively collected from 606 prevalent PD patients
between August 2001 and August 2011. The diagnosis of EPS was based on
clinical signs and symptoms, mostly conﬁrmed by radiological ﬁndings.
Eight patients (incidence rate of 1.3%) were diagnosed with EPS. Theyhad at least one of three symptoms: abdominal pain, vomiting, or
abdominal distension. Mean age of the patients (4 males and 4 females)
was 48.5 (range: 33 to 65) years. Mean duration of PD was 111.8 (range: 23
to 186) months. The causes of ESRD were chronic glomerulonephritis
(n¼6), followed by hypertensive nephrosclerosis (n¼1) and diabetic
nephropathy (n¼1). All the patients except one had 3 or more episodes of
peritonitis. Seven patients were diagnosed with EPS after stopping PD and
only one stayed on PD after initial diagnosis and treatment. The use of
icodextrin or beta-blockers and angiotensin-converting enzyme inhibitors
or angiotensin II receptor blockers was not different in the patients without
EPS. Total parenteral nutrition was used in all patients. Three patients were
treated with corticosteroids (0.51 mg/kg/day) in addition to tamoxifen
(10–20 mg daily) and four with only total parenteral nutrition. Only one
patient received corticosteroids (1 mg/kg/day) combined with elective
surgical intervention, adhesiolysis. Of the 8 patients diagnosed with EPS,
4 died with an overall mortality rate of 50%.
In this retrospective analysis, we conﬁrmed that EPS is rare but a serious
life threatening complication in patients on long-term PD. To reduce the
incidence and mortality of EPS, careful monitoring and early diagnosis may
be needed.
http://dx.doi.org/10.1016/j.krcp.2012.04.40380
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Nutrition is one of the important issues and edema will overestimate the
real body weight among dialysis patients. Lean body mass might reﬂect the
real nutrition status. Creatinine is the product of muscle metabolism,
creatinine generation can reﬂect the lean body mass (LBM). In peritoneal
dialysis (PD) patients, creatinine generation could be evaluated by routine
clearance measurement. This study will investigate the relationship among
LBM, patient survival and PD technique therapy. Between 2002 and 2003, a
total 115 patients who underwent PD for more than 3 months were
enrolled in this study. Follow up ended in Dec. 2011. These patients were
categorized into two groups according the median value of lean body mass
to body weight (LBM/BW %) evaluated at ﬁrst month. Age, sex, serum
creatinine, albumin, and normalized protein catabolic rate (nPCR) were the
independent determinants for LBM/BW%. The patient survival (68 vs 94
months ) and technique survival (55 vs 65 months) were longer in the
higher LBM/BW%. Besides, peritonitis incidence, hospitalization episodes
and hospitalization stay duration were lower in the higher LBM/BW%
groups. The LBM/BW% is also the independent determinant for technique
and patient survival after adjustment of age, diabetes, sex.
In conclusion, initial LBM/BM% can predict PD patients and technique
survival. Since the LBM/BW% is easily obtained in the routine PD clearance
measurement and can reﬂect the real nutrition status, this parameter could
be used extendedly to predict PD outcomes.
http://dx.doi.org/10.1016/j.krcp.2012.04.40481
ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IS INCREASED
FOLLOWING MISSED DIALYSIS SESSIONS
T. Christopher Bond 1, Steven Wang 1, Jaime Rubin 1, Alex Yang 2
1
DaVita Clinical Research, Minneapolis, MN, USA
2
Affymax, Palo Alto, CA, USA
Missed dialysis sessions can have a cascading effect on patient clinical
outcomes. In addition to missing the dialysis itself, patients fail to receive
medications—such as ESAs—that are dosed at each session. This analysis
assessed ESA dose changes following missed session episodes in order to
evaluate ‘‘catch-up dosing.’’
In a retrospective analysis, we assessed missed session and epoetin alfa
(EPO) utilization data in 2010 from adult (Z 18 yrs old), hemodialysis (HD)
patients. Consecutive misses were considered part of a missed session
‘‘episode.’’ All misses were included (even if patient was hospitalized).
Differences in EPO utilization in the periods 14 days, 30 days and 31-60
days before and after missed session episodes were calculated and
stratiﬁed by length of episode, and whether additional sessions were
missed in the before/after periods. Total monthly EPO dose was also
calculated and stratiﬁed by number of missed sessions.
